These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1256 related items for PubMed ID: 19951637

  • 1. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
    Alexandrescu DT.
    Dermatol Online J; 2009 Nov 15; 15(11):1. PubMed ID: 19951637
    [Abstract] [Full Text] [Related]

  • 2. Investment in new technology research can save future health care dollars.
    Reintgen D, Albertini J, Milliotes G, Marshburn J, Cruse CW, Rapaport D, Berman C, Glass F, Fensske N, Einstein AB, Lyman G.
    J Fla Med Assoc; 1997 Mar 15; 84(3):175-81. PubMed ID: 9143169
    [Abstract] [Full Text] [Related]

  • 3. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.
    Seidler AM, Pennie ML, Veledar E, Culler SD, Chen SC.
    Arch Dermatol; 2010 Mar 15; 146(3):249-56. PubMed ID: 20231494
    [Abstract] [Full Text] [Related]

  • 4. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
    Chevalier J, Bonastre J, Avril MF.
    Melanoma Res; 2008 Feb 15; 18(1):40-6. PubMed ID: 18227707
    [Abstract] [Full Text] [Related]

  • 5. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
    Johnston K, Levy AR, Lorigan P, Maio M, Lebbe C, Middleton M, Testori A, Bédane C, Konto C, Dueymes A, Sbarigia U, van Baardewijk M.
    Eur J Cancer; 2012 Sep 15; 48(14):2175-82. PubMed ID: 22480965
    [Abstract] [Full Text] [Related]

  • 6. Cumulative cost pattern comparison of prostate cancer treatments.
    Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR.
    Cancer; 2007 Feb 01; 109(3):518-27. PubMed ID: 17186528
    [Abstract] [Full Text] [Related]

  • 7. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
    Evans WK, Will BP, Berthelot JM, Wolfson MC.
    Can J Oncol; 1995 Dec 01; 5(4):408-19. PubMed ID: 8770457
    [Abstract] [Full Text] [Related]

  • 8. [Costs of initial cancer care and its affecting factors].
    Kim SY, Kim SG, Park JH, Park EC.
    J Prev Med Public Health; 2009 Jul 01; 42(4):243-50. PubMed ID: 19675401
    [Abstract] [Full Text] [Related]

  • 9. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A, Wanek LA, Morton DL.
    J Am Coll Surg; 1995 Sep 01; 181(3):193-201. PubMed ID: 7670677
    [Abstract] [Full Text] [Related]

  • 10. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
    Poo-Hwu WJ, Ariyan S, Lamb L, Papac R, Zelterman D, Hu GL, Brown J, Fischer D, Bolognia J, Buzaid AC.
    Cancer; 1999 Dec 01; 86(11):2252-8. PubMed ID: 10590365
    [Abstract] [Full Text] [Related]

  • 11. [Descriptive study of the costs of diagnosis and treatment of cutaneous melanoma].
    Almazán-Fernández FM, Serrano-Ortega S, Moreno-Villalonga JJ.
    Actas Dermosifiliogr; 2009 Nov 01; 100(9):785-91. PubMed ID: 19889300
    [Abstract] [Full Text] [Related]

  • 12. An estimate of the annual direct cost of treating cutaneous melanoma.
    Tsao H, Rogers GS, Sober AJ.
    J Am Acad Dermatol; 1998 May 01; 38(5 Pt 1):669-80. PubMed ID: 9591809
    [Abstract] [Full Text] [Related]

  • 13. [Advanced breast cancer: an evaluation of the cost of recurrence].
    Bercez C, Lebrun T, Bonneterre ME, Selke B, Lenne X, Bonneterre J.
    Bull Cancer; 1999 Jun 01; 86(6):585-90. PubMed ID: 10417432
    [Abstract] [Full Text] [Related]

  • 14. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
    Francken AB, Accortt NA, Shaw HM, Wiener M, Soong SJ, Hoekstra HJ, Thompson JF.
    Ann Surg Oncol; 2008 May 01; 15(5):1476-84. PubMed ID: 18196345
    [Abstract] [Full Text] [Related]

  • 15. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
    Lee SH, Hernandez de Anda E, Finne CO, Madoff RD, Garcia-Aguilar J.
    Dis Colon Rectum; 2005 Dec 01; 48(12):2249-57. PubMed ID: 16400512
    [Abstract] [Full Text] [Related]

  • 16. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L, Bowman L, Chang S, Long SR, Obasaju C, Crown WH.
    Lung Cancer; 2005 Nov 01; 50(2):143-54. PubMed ID: 16112249
    [Abstract] [Full Text] [Related]

  • 17. The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma.
    Oestreicher N, Ramsey SD, McCune JS, Linden HM, Veenstra DL.
    Cancer; 2005 Nov 15; 104(10):2054-62. PubMed ID: 16216002
    [Abstract] [Full Text] [Related]

  • 18. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM, Blum D, Ubel PA, Schnipper LE, American Society of Clinical Oncology.
    J Clin Oncol; 2009 Aug 10; 27(23):3868-74. PubMed ID: 19581533
    [Abstract] [Full Text] [Related]

  • 19. Costs of the detection of metastases and follow-up examinations in cutaneous melanoma.
    Leiter U, Marghoob AA, Lasithiotakis K, Eigentler TK, Meier F, Meisner C, Garbe C.
    Melanoma Res; 2009 Feb 10; 19(1):50-7. PubMed ID: 19430406
    [Abstract] [Full Text] [Related]

  • 20. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006.
    Ekwueme DU, Guy GP, Li C, Rim SH, Parelkar P, Chen SC.
    J Am Acad Dermatol; 2011 Nov 10; 65(5 Suppl 1):S133-43. PubMed ID: 22018062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.